MAP2K1 and breast cancer: CEP55 is upregulated when the MEK1/2‐MYC pathway is activated in breast cancer cells and is essential for breast cancer cell aneuploidy, proliferation, and survival [37], and CEP55 overexpression in primary breast tumor tissues is a marker for chromosomal instability and poor prognosis [37, 38].